Noteworthy enrichment pathways included “Negative Regulation of the PI3K/Akt Network”, “PI3P, PP2A, and IER3 Regulate PI3K/AKT Signalling”, and “PI3K/AKT Signalling in Cancer” (Figure 1D). The gene discussed is AKT1; the disease is cancer.